Statins and glycaemic control in individuals with diabetes: a systematic review and meta-analysis

An assessment by the Statin Diabetes Safety Task Force: 2014 update

(2014) Kevin C. Maki et al.   Journal of Clinical Lipidology

2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults

(2013) Neil J. Stone et al.   CIRCULATION

Effect of high-dose pitavastatin on glucose homeostasis in patients at elevated risk of new-onset diabetes: insights from the CAPITAIN and PREVAIL-US studies

(2013) M. J. Chapman et al.   CURRENT MEDICAL RESEARCH AND OPINION

The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials

(2013)   LANCET

Pitavastatin and Atorvastatin Double-Blind Randomized ComPArative Study among HiGh-Risk Patients, Including ThOse with Type 2 Diabetes Mellitus, in Taiwan (PAPAGO-T Study)

(2013) Ping-Yen Liu et al.   PLoS One

Risk of incident diabetes among patients treated with statins: population based study

(2013) A. A. Carter et al.   BMJ-British Medical Journal

Statins and diabetes risk: Fact, fiction, and clinical implications

(2012) M. B. ROCCO   CLEVELAND CLINIC JOURNAL OF MEDICINE

Statins: Is It Really Time to Reassess Benefits and Risks?

(2012) Allison B. Goldfine   NEW ENGLAND JOURNAL OF MEDICINE

Comparative long-term efficacy and tolerability of pitavastatin 4 mg and atorvastatin 20-40 mg in patients with type 2 diabetes mellitus and combined (mixed) dyslipidaemia

(2011) J. Gumprecht et al.   DIABETES OBESITY & METABOLISM

Effects of rosuvastatin and atorvastatin on glycaemic control in Type 2 diabetes-the CORALL study

(2011) S. Simsek et al.   DIABETIC MEDICINE

Risk of Incident Diabetes With Intensive-Dose Compared With Moderate-Dose Statin Therapy

(2011) David Preiss   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Influence of Pitavastatin on Glucose Tolerance in Patients with Type 2 Diabetes Mellitus

(2011) Tadashi Yamakawa et al.   Journal of Atherosclerosis and Thrombosis

Impact of atorvastatin and omega-3 ethyl esters 90 on plasma plant sterol concentrations and cholesterol synthesis in type 2 diabetes: A randomised placebo controlled factorial trial

(2010) H.A.W. Neil et al.   ATHEROSCLEROSIS

Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies

(2010) The Emerging Risk Factors Collaboration   LANCET

Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials

(2010) Naveed Sattar et al.   LANCET

Effect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus: a meta-analysis of randomised controlled trials

(2009) Kausik K Ray et al.   LANCET

Pravastatin reduces the risk for cardiovascular disease in Japanese hypercholesterolemic patients with impaired fasting glucose or diabetes: Diabetes subanalysis of the Management of Elevated Cholesterol in the Primary Prevention Group of Adult Japanese (MEGA) Study

(2008) Naoko Tajima et al.   ATHEROSCLEROSIS

Atorvastatin in Factorial with Omega-3 EE90 Risk Reduction in Diabetes (AFORRD): a randomised controlled trial

(2008) R. R. Holman et al.   DIABETOLOGIA

Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein

(2008) Paul M Ridker et al.   NEW ENGLAND JOURNAL OF MEDICINE

Effect of atorvastatin on endothelial function and inflammation in long-duration type 1 diabetic patients without coronary heart disease and arterial hypertension

(2007) E. Konduracka et al.   DIABETES OBESITY & METABOLISM